Related references
Note: Only part of the references are listed.Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype
John Henry McDermott et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
The implementation of an aminoglycoside induced ototoxicity algorithm for people with cystic fibrosis
E. Claire Elson et al.
JOURNAL OF CYSTIC FIBROSIS (2021)
Measurement of gene amplifications related to drug resistance in Plasmodium falciparum using droplet digital PCR
Suttipat Srisutham et al.
MALARIA JOURNAL (2021)
Noninvasive and Accurate Detection of Hereditary Hearing Loss Mutations with Buccal Swab Based on Droplet Digital PCR
Fang Wang et al.
ANALYTICAL CHEMISTRY (2018)
Progressive Hearing Loss among Patients with Cystic Fibrosis and Parenteral Aminoglycoside Treatment
Erika M. Zettner et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2018)
The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis
Angela C. Garinis et al.
JOURNAL OF CYSTIC FIBROSIS (2017)
Aminoglycosides: An Overview
Kevin M. Krause et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Analysis of the heteroplasmy level and transmitted features in hearing-loss pedigrees with mitochondrial 12S rRNA A1555G mutation
Yuhua Zhu et al.
BMC GENETICS (2014)
American College of Medical Genetics and Genomics guideline for the clinical evaluation and etiologic diagnosis of hearing loss
Raye L. Alford et al.
GENETICS IN MEDICINE (2014)
Normal hearing in a child with the m.1555A>G mutation despite repeated exposure to aminoglycosides. Has the penetrance of this pharmacogenetic interaction been overestimated?
Ghada Al-Malky et al.
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY (2014)
The Clinical and Audiologic Features of Hearing Loss Due to Mitochondrial Mutations
Joshua C. Yelverton et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2013)
The Clinical and Audiologic Features of Hearing Loss Due to Mitochondrial Mutations
Joshua C. Yelverton et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2013)
High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
Benjamin J. Hindson et al.
ANALYTICAL CHEMISTRY (2011)
The Prevalence of Mitochondrial Mutations Associated with Aminoglycoside-Induced Sensorineural Hearing Loss in an NICU Population
Megan Ealy et al.
LARYNGOSCOPE (2011)
Aminoglycoside-induced deafness during treatment of acute leukaemia
M. Bitner-Glindzicz et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2010)
Interaction of Aminoglycosides with Human Mitochondrial 12S rRNA Carrying the Deafness-Associated Mutation
Yaping Qian et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Prevalence of Mitochondrial 1555A>G Mutation in Adults of European Descent
Himesha Vandebona et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Frequency of mitochondrial 12S ribosomal RNA variants in an adult cystic fibrosis population
Douglas J. Conrad et al.
PHARMACOGENETICS AND GENOMICS (2008)
Pharmacogenomic testing to prevent aminoglycoside-induced hearing loss in cystic fibrosis patients: potential impact on clinical, patient, and economic outcomes
David L. Veenstra et al.
GENETICS IN MEDICINE (2007)
A review of cochlear implantation in mitochondrial sensorineural hearing loss
AR Sinnathuray et al.
OTOLOGY & NEUROTOLOGY (2003)
Acute renal failure in cystic fibrosis: Association with inhaled tobramycin therapy
IM Hoffmann et al.
PEDIATRIC PULMONOLOGY (2002)
Different clinical characteristics of aminoglycoside-induced profound deafness with and without the 1555 A -> G mitochondrial mutation
T Tono et al.
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES (2001)
Prevalence of mitochondrial gene mutations among hearing impaired patients
S Usami et al.
JOURNAL OF MEDICAL GENETICS (2000)
Share Paper
